Literature DB >> 1414678

The selective protection afforded by ebselen against lipid peroxidation in an ROS-dependent model of inflammation.

H R Griffiths1, E J Dowling, T Sahinoglu, D R Blake, M Parnham, J Lunec.   

Abstract

The effects of an experimental model of hydrogen-peroxide-induced foot pad oedema on indices of oxidative damage to biomolecules have been investigated. We have demonstrated increased levels of fluorescent protein and lipid peroxides occurring in plasma at 24 and 48 h post-injection. In addition, a decrease in the degree of galactosylation of IgG was observed which kinetically related the degree of inflammation and to the increase in protein autofluorescence (a specific index of oxidative damage). The effects of ebselen, a novel organoselenium compound which protects against oxidative tissue injury in a glutathione-peroxidase-like manner, have also been examined in this model. Pretreatment of animals with a dose of 50 mg/kg ebselen afforded significant and selective protection against lipid peroxidation only. This effect may contribute to the anti-inflammatory effect of this agent in hydroperoxide-linked tissue damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414678     DOI: 10.1007/bf01991237

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

Review 1.  Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions.

Authors:  M J Parnham; E Graf
Journal:  Biochem Pharmacol       Date:  1987-10-01       Impact factor: 5.858

Review 2.  Protein fluorescence and its relationship to free radical activity.

Authors:  A F Jones; J Lunec
Journal:  Br J Cancer Suppl       Date:  1987-06

3.  The inhibition of lipid autoxidation by human serum and its relation to serum proteins and alpha-tocopherol.

Authors:  J Stocks; J M Gutteridge; R J Sharp; T L Dormandy
Journal:  Clin Sci Mol Med       Date:  1974-09

4.  The effects of oxygen free radicals on the carbohydrate moiety of IgG.

Authors:  H R Griffiths; J Lunec
Journal:  FEBS Lett       Date:  1989-03-13       Impact factor: 4.124

Review 5.  Oxidants, inflammation, and anti-inflammatory drugs.

Authors:  B Halliwell; J R Hoult; D R Blake
Journal:  FASEB J       Date:  1988-10       Impact factor: 5.191

6.  Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.

Authors:  R Dubé; G A Rook; J Steele; R Brealey; R Dwek; T Rademacher; J Lennard-Jones
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

7.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

Authors:  R B Parekh; R A Dwek; B J Sutton; D L Fernandes; A Leung; D Stanworth; T W Rademacher; T Mizuochi; T Taniguchi; K Matsuta
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

8.  Reduced B-cell galactosyltransferase activity in rheumatoid arthritis.

Authors:  J S Axford; L Mackenzie; P M Lydyard; F C Hay; D A Isenberg; I M Roitt
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

  8 in total
  2 in total

1.  Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients.

Authors:  A Youings; S C Chang; R A Dwek; I G Scragg
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

2.  Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.

Authors:  Barbara Costa; Mariapia Colleoni; Silvia Conti; Daniela Parolaro; Chiara Franke; Anna Elisa Trovato; Gabriella Giagnoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-12       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.